| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
A4GALT
|
alpha 1,4-galactosyltransferase
|
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACR
|
acrosin
|
|
ACY1
|
aminoacylase 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADGRF5
|
adhesion G protein-coupled receptor F5
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AFG3L2
|
AFG3-like AAA ATPase 2
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
AGR2
|
anterior gradient 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTRAP
|
angiotensin II receptor-associated protein
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIM2
|
absent in melanoma 2
|
|
AKAP10
|
A kinase (PRKA) anchor protein 10
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1B15
|
aldo-keto reductase family 1, member B15
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALDH3A2
|
aldehyde dehydrogenase 3 family, member A2
|
|
ALDH3B1
|
aldehyde dehydrogenase 3 family, member B1
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALKBH2
|
alkB, alkylation repair homolog 2 (E. coli)
|
|
ALKBH5
|
AlkB family member 5, RNA demethylase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
AMH
|
anti-Mullerian hormone
|
|
AMY2A
|
amylase, alpha 2A (pancreatic)
|
|
ANAPC11
|
anaphase promoting complex subunit 11
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANTXR1
|
anthrax toxin receptor 1
|
|
ANTXR2
|
anthrax toxin receptor 2
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLNR
|
apelin receptor
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA1BP
|
apolipoprotein A-I binding protein
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3D
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOC1
|
apolipoprotein C-I
|
|
APOC3
|
apolipoprotein C-III
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AQP8
|
aquaporin 8
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARHGAP1
|
Rho GTPase activating protein 1
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like)
|
|
ARRB2
|
arrestin, beta 2
|
|
ARSA
|
arylsulfatase A
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATG4A
|
autophagy related 4A, cysteine peptidase
|
|
ATG4B
|
autophagy related 4B, cysteine peptidase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
|
ATP5I
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E
|
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
|
|
ATP6V0D1
|
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1
|
|
ATP6V0D2
|
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZU1
|
azurocidin 1
|
|
B2M
|
beta-2-microglobulin
|
|
BAAT
|
bile acid CoA:amino acid N-acyltransferase
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAG5
|
BCL2-associated athanogene 5
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BICC1
|
BicC family RNA binding protein 1
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC6
|
baculoviral IAP repeat containing 6
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTF3
|
basic transcription factor 3
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C11ORF31
|
chromosome 11 open reading frame 31
|
|
C19ORF40
|
chromosome 19 open reading frame 40
|
|
C19ORF48
|
chromosome 19 open reading frame 48
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA2
|
carbonic anhydrase II
|
|
CACUL1
|
CDK2-associated, cullin domain 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCOCO2
|
calcium binding and coiled-coil domain 2
|
|
CALR
|
calreticulin
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP12
|
caspase 12 (gene/pseudogene)
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCK
|
cholecystokinin
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD160
|
CD160 molecule
|
|
CD163
|
CD163 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD37
|
CD37 molecule
|
|
CD38
|
CD38 molecule
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD53
|
CD53 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD70
|
CD70 molecule
|
|
CD80
|
CD80 molecule
|
|
CD81
|
CD81 molecule
|
|
CD86
|
CD86 molecule
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK11B
|
cyclin-dependent kinase 11B
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CERK
|
ceramide kinase
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFHR3
|
complement factor H-related 3
|
|
CFI
|
complement factor I
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFP
|
complement factor properdin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CHAF1A
|
chromatin assembly factor 1, subunit A (p150)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CKB
|
creatine kinase, brain
|
|
CKM
|
creatine kinase, muscle
|
|
CLDN1
|
claudin 1
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLDN5
|
claudin 5
|
|
CLDN7
|
claudin 7
|
|
CLEC11A
|
C-type lectin domain family 11, member A
|
|
CLEC1B
|
C-type lectin domain family 1, member B
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family)
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COLEC11
|
collectin sub-family member 11
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CPT1C
|
carnitine palmitoyltransferase 1C
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRISPLD2
|
cysteine-rich secretory protein LCCL domain containing 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBB1
|
crystallin, beta B1
|
|
CRYGS
|
crystallin, gamma S
|
|
CRYZ
|
crystallin, zeta (quinone reductase)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CST11
|
cystatin 11
|
|
CST3
|
cystatin C
|
|
CST9
|
cystatin 9 (testatin)
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTAG2
|
cancer/testis antigen 2
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CTSE
|
cathepsin E
|
|
CTSG
|
cathepsin G
|
|
CTSK
|
cathepsin K
|
|
CTSV
|
cathepsin V
|
|
CUL5
|
cullin 5
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYGB
|
cytoglobin
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DAXX
|
death-domain associated protein
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCK
|
deoxycytidine kinase
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDOST
|
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic)
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX39A
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A
|
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA1B
|
defensin, alpha 1B
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFA6
|
defensin, alpha 6, Paneth cell-specific
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103A
|
defensin, beta 103A
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB104A
|
defensin, beta 104A
|
|
DEFB104B
|
defensin, beta 104B
|
|
DEFB105A
|
defensin, beta 105A
|
|
DEFB105B
|
defensin, beta 105B
|
|
DEFB106A
|
defensin, beta 106A
|
|
DEFB106B
|
defensin, beta 106B
|
|
DEFB114
|
defensin, beta 114
|
|
DEFB118
|
defensin, beta 118
|
|
DEFB126
|
defensin, beta 126
|
|
DEFB132
|
defensin, beta 132
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEFB4B
|
defensin, beta 4B
|
|
DGUOK
|
deoxyguanosine kinase
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DHODH
|
dihydroorotate dehydrogenase (quinone)
|
|
DHRS2
|
dehydrogenase/reductase (SDR family) member 2
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLD
|
dihydrolipoamide dehydrogenase
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DNAJA1
|
DnaJ (Hsp40) homolog, subfamily A, member 1
|
|
DNAJB11
|
DnaJ (Hsp40) homolog, subfamily B, member 11
|
|
DNAJC2
|
DnaJ (Hsp40) homolog, subfamily C, member 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DSC3
|
desmocollin 3
|
|
DSG1
|
desmoglein 1
|
|
DSG2
|
desmoglein 2
|
|
DSG3
|
desmoglein 3
|
|
DSP
|
desmoplakin
|
|
DST
|
dystonin
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECI2
|
enoyl-CoA delta isomerase 2
|
|
EDN1
|
endothelin 1
|
|
EFNA1
|
ephrin-A1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGR1
|
early growth response 1
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF3A
|
eukaryotic translation initiation factor 3, subunit A
|
|
EIF4A1
|
eukaryotic translation initiation factor 4A1
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
EMILIN2
|
elastin microfibril interfacer 2
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENO3
|
enolase 3 (beta, muscle)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPO
|
erythropoietin
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
EREG
|
epiregulin
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV6
|
ets variant 6
|
|
EXO1
|
exonuclease 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F13B
|
coagulation factor XIII, B polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FAU
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR2C
|
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FCRL3
|
Fc receptor-like 3
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FGB
|
fibrinogen beta chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGG
|
fibrinogen gamma chain
|
|
FHIT
|
fragile histidine triad
|
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FNTB
|
farnesyltransferase, CAAX box, beta
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FTMT
|
ferritin mitochondrial
|
|
FTO
|
fat mass and obesity associated
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
FXYD3
|
FXYD domain containing ion transport regulator 3
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABARAPL2
|
GABA(A) receptor-associated protein-like 2
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALP
|
galanin-like peptide
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA3
|
GATA binding protein 3
|
|
GBA
|
glucosidase, beta, acid
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GEMIN2
|
gem (nuclear organelle) associated protein 2
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GFI1B
|
growth factor independent 1B transcription repressor
|
|
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA4
|
gap junction protein, alpha 4, 37kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GLO1
|
glyoxalase I
|
|
GLRX2
|
glutaredoxin 2
|
|
GNLY
|
granulysin
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPC3
|
glypican 3
|
|
GPC5
|
glypican 5
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPR65
|
G protein-coupled receptor 65
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GPX7
|
glutathione peroxidase 7
|
|
GRIK4
|
glutamate receptor, ionotropic, kainate 4
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSR
|
glutathione reductase
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GSTA4
|
glutathione S-transferase alpha 4
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF3C2
|
general transcription factor IIIC, polypeptide 2, beta 110kDa
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC9
|
histone deacetylase 9
|
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST1H2BC
|
histone cluster 1, H2bc
|
|
HIST1H2BE
|
histone cluster 1, H2be
|
|
HIST1H2BF
|
histone cluster 1, H2bf
|
|
HIST1H2BG
|
histone cluster 1, H2bg
|
|
HIST1H2BI
|
histone cluster 1, H2bi
|
|
HIST2H2BE
|
histone cluster 2, H2be
|
|
HK2
|
hexokinase 2
|
|
HK3
|
hexokinase 3 (white cell)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLTF
|
helicase-like transcription factor
|
|
HMBOX1
|
homeobox containing 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
HP
|
haptoglobin
|
|
HPSE
|
heparanase
|
|
HRG
|
histidine-rich glycoprotein
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA2P
|
heat shock protein 90kDa alpha (cytosolic), class A member 2, pseudogene
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA12B
|
heat shock 70kD protein 12B
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA2
|
heat shock 70kDa protein 2
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular)
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPE1
|
heat shock 10kDa protein 1
|
|
HTN3
|
histatin 3
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTT
|
huntingtin
|
|
HUWE1
|
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
|
|
HYOU1
|
hypoxia up-regulated 1
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDDM17
|
insulin-dependent diabetes mellitus 17
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFITM2
|
interferon induced transmembrane protein 2
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGLON5
|
IgLON family member 5
|
|
IHH
|
indian hedgehog
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL11
|
interleukin 11
|
|
IL11RA
|
interleukin 11 receptor, alpha
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL20RA
|
interleukin 20 receptor, alpha
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL26
|
interleukin 26
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL37
|
interleukin 37
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL9
|
interleukin 9
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
ILK
|
integrin-linked kinase
|
|
IMPACT
|
impact RWD domain protein
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSR
|
insulin receptor
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF2
|
interferon regulatory factor 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF9
|
interferon regulatory factor 9
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRS3P
|
insulin receptor substrate 3, pseudogene
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
IZUMO1
|
izumo sperm-egg fusion 1
|
|
JAK2
|
Janus kinase 2
|
|
JARID2
|
jumonji, AT rich interactive domain 2
|
|
JMJD6
|
jumonji domain containing 6
|
|
JUN
|
jun proto-oncogene
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM4D
|
lysine (K)-specific demethylase 4D
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA0226
|
KIAA0226
|
|
KIF2C
|
kinesin family member 2C
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KIRREL2
|
kin of IRRE like 2 (Drosophila)
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLF15
|
Kruppel-like factor 15
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF7
|
Kruppel-like factor 7 (ubiquitous)
|
|
KLHDC8B
|
kelch domain containing 8B
|
|
KLK1
|
kallikrein 1
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT6A
|
keratin 6A, type II
|
|
LALBA
|
lactalbumin, alpha-
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEAP2
|
liver expressed antimicrobial peptide 2
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX4
|
LIM homeobox 4
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LIPC
|
lipase, hepatic
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LPL
|
lipoprotein lipase
|
|
LPO
|
lactoperoxidase
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LRP4
|
low density lipoprotein receptor-related protein 4
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRC7
|
leucine rich repeat containing 7
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
LY96
|
lymphocyte antigen 96
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA6
|
melanoma antigen family A6
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAOA
|
monoamine oxidase A
|
|
MAP1LC3C
|
microtubule-associated protein 1 light chain 3 gamma
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCH5
|
membrane-associated ring finger (C3HC4) 5
|
|
MARCO
|
macrophage receptor with collagenous structure
|
|
MAS1
|
MAS1 proto-oncogene, G protein-coupled receptor
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MAT2B
|
methionine adenosyltransferase II, beta
|
|
MBL1P
|
mannose-binding lectin (protein A) 1, pseudogene
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCOLN1
|
mucolipin 1
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MCU
|
mitochondrial calcium uniporter
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
METAP1
|
methionyl aminopeptidase 1
|
|
MFN2
|
mitofusin 2
|
|
MGAT2
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGST1
|
microsomal glutathione S-transferase 1
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106B
|
microRNA 106b
|
|
MIR122
|
microRNA 122
|
|
MIR125A
|
microRNA 125a
|
|
MIR130B
|
microRNA 130b
|
|
MIR132
|
microRNA 132
|
|
MIR135B
|
microRNA 135b
|
|
MIR138-2
|
microRNA 138-2
|
|
MIR140
|
microRNA 140
|
|
MIR145
|
microRNA 145
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR182
|
microRNA 182
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR204
|
microRNA 204
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR23A
|
microRNA 23a
|
|
MIR27A
|
microRNA 27a
|
|
MIR2909
|
microRNA 2909
|
|
MIR29A
|
microRNA 29a
|
|
MIR34A
|
microRNA 34a
|
|
MIR494
|
microRNA 494
|
|
MIR503
|
microRNA 503
|
|
MIR551B
|
microRNA 551b
|
|
MLH1
|
mutL homolog 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MMD
|
monocyte to macrophage differentiation-associated
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSMB
|
microseminoprotein, beta-
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MSRB1
|
methionine sulfoxide reductase B1
|
|
MSRB3
|
methionine sulfoxide reductase B3
|
|
MT2A
|
metallothionein 2A
|
|
MT3
|
metallothionein 3
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRNR2L1
|
MT-RNR2-like 1
|
|
MTRNR2L10
|
MT-RNR2-like 10
|
|
MTRNR2L2
|
MT-RNR2-like 2
|
|
MTRNR2L3
|
MT-RNR2-like 3
|
|
MTRNR2L4
|
MT-RNR2-like 4
|
|
MTRNR2L5
|
MT-RNR2-like 5
|
|
MTRNR2L6
|
MT-RNR2-like 6
|
|
MTRNR2L7
|
MT-RNR2-like 7
|
|
MTRNR2L8
|
MT-RNR2-like 8
|
|
MTRNR2L9
|
MT-RNR2-like 9
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MTSS1
|
metastasis suppressor 1
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUC7
|
mucin 7, secreted
|
|
MUTYH
|
mutY homolog
|
|
MVP
|
major vault protein
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO18A
|
myosin XVIIIA
|
|
MYO5B
|
myosin VB
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYPN
|
myopalladin
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAPEPLD
|
N-acyl phosphatidylethanolamine phospholipase D
|
|
NAPRT
|
nicotinate phosphoribosyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEFM
|
neurofilament, medium polypeptide
|
|
NEK2
|
NIMA-related kinase 2
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NGB
|
neuroglobin
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NISCH
|
nischarin
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP5
|
NLR family, pyrin domain containing 5
|
|
NLRX1
|
NLR family member X1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMU
|
neuromedin U
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPEPPS
|
aminopeptidase puromycin sensitive
|
|
NPFFR2
|
neuropeptide FF receptor 2
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRG1
|
neuregulin 1
|
|
NT5C2
|
5'-nucleotidase, cytosolic II
|
|
NT5DC1
|
5'-nucleotidase domain containing 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTN1
|
netrin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTS
|
neurotensin
|
|
NUCB2
|
nucleobindin 2
|
|
NUDCD1
|
NudC domain containing 1
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
NUDT15
|
nudix (nucleoside diphosphate linked moiety X)-type motif 15
|
|
NUDT18
|
nudix (nucleoside diphosphate linked moiety X)-type motif 18
|
|
NUDT5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NXNL1
|
nucleoredoxin-like 1
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OIT3
|
oncoprotein induced transcript 3
|
|
OLFM4
|
olfactomedin 4
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
ORM1
|
orosomucoid 1
|
|
OXR1
|
oxidation resistance 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PAFAH1B2
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)
|
|
PAFAH2
|
platelet-activating factor acetylhydrolase 2, 40kDa
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX9
|
paired box 9
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDF
|
peptide deformylase (mitochondrial)
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDPN
|
podoplanin
|
|
PDZD2
|
PDZ domain containing 2
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER1
|
period circadian clock 1
|
|
PF4
|
platelet factor 4
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G5
|
phospholipase A2, group V
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLIN2
|
perilipin 2
|
|
PLIN3
|
perilipin 3
|
|
PLK1
|
polo-like kinase 1
|
|
PLOD2
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POLM
|
polymerase (DNA directed), mu
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PON3
|
paraoxonase 3
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP3R1
|
protein phosphatase 3, regulatory subunit B, alpha
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRG4
|
proteoglycan 4
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRL
|
prolactin
|
|
PRM1
|
protamine 1
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROX1
|
prospero homeobox 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PRSS8
|
protease, serine, 8
|
|
PRTN3
|
proteinase 3
|
|
PSAP
|
prosaposin
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTMA
|
prothymosin, alpha
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTX3
|
pentraxin 3, long
|
|
PVALB
|
parvalbumin
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PYY
|
peptide YY
|
|
RAB11A
|
RAB11A, member RAS oncogene family
|
|
RAB3A
|
RAB3A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RANBP2
|
RAN binding protein 2
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2
|
|
RBMXP1
|
RNA binding motif protein, X-linked pseudogene 1
|
|
RBP3
|
retinol binding protein 3, interstitial
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RDH12
|
retinol dehydrogenase 12 (all-trans/9-cis/11-cis)
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REG1B
|
regenerating islet-derived 1 beta
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
REG3G
|
regenerating islet-derived 3 gamma
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
REN
|
renin
|
|
RETN
|
resistin
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RGS7BP
|
regulator of G-protein signaling 7 binding protein
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNASE6
|
ribonuclease, RNase A family, k6
|
|
RNASE7
|
ribonuclease, RNase A family, 7
|
|
RNASE8
|
ribonuclease, RNase A family, 8
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
RNR2
|
RNA, ribosomal cluster 2
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROPN1
|
rhophilin associated tail protein 1
|
|
RORC
|
RAR-related orphan receptor C
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPLP0
|
ribosomal protein, large, P0
|
|
RPLP1
|
ribosomal protein, large, P1
|
|
RPLP2
|
ribosomal protein, large, P2
|
|
RPS3
|
ribosomal protein S3
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPSA
|
ribosomal protein SA
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RSPO1
|
R-spondin 1
|
|
RTN4
|
reticulon 4
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAA1
|
serum amyloid A1
|
|
SAMD9
|
sterile alpha motif domain containing 9
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SATB2
|
SATB homeobox 2
|
|
SAV1
|
salvador family WW domain containing protein 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCFV
|
single-chain Fv fragment
|
|
SCG2
|
secretogranin II
|
|
SCG3
|
secretogranin III
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCP2
|
sterol carrier protein 2
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SECISBP2
|
SECIS binding protein 2
|
|
SELE
|
selectin E
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SEPN1
|
selenoprotein N, 1
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SEPT5
|
septin 5
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SESN2
|
sestrin 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPB
|
surfactant protein B
|
|
SFTPC
|
surfactant protein C
|
|
SFTPD
|
surfactant protein D
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGMS1
|
sphingomyelin synthase 1
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH2D1B
|
SH2 domain containing 1B
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT3
|
sirtuin 3
|
|
SIRT4
|
sirtuin 4
|
|
SIVA1
|
SIVA1, apoptosis-inducing factor
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6
|
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC25A15
|
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15
|
|
SLC25A27
|
solute carrier family 25, member 27
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC30A10
|
solute carrier family 30, member 10
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC32A1
|
solute carrier family 32 (GABA vesicular transporter), member 1
|
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD1
|
SMAD family member 1
|
|
SMG1
|
SMG1 phosphatidylinositol 3-kinase-related kinase
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCAIP
|
synuclein, alpha interacting protein
|
|
SNCB
|
synuclein, beta
|
|
SNIP1
|
Smad nuclear interacting protein 1
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SPAG11B
|
sperm associated antigen 11B
|
|
SPAG16
|
sperm associated antigen 16
|
|
SPAG4
|
sperm associated antigen 4
|
|
SPAG9
|
sperm associated antigen 9
|
|
SPDYA
|
speedy/RINGO cell cycle regulator family member A
|
|
SPINK9
|
serine peptidase inhibitor, Kazal type 9
|
|
SPN
|
sialophorin
|
|
SPON2
|
spondin 2, extracellular matrix protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRTN
|
SprT-like N-terminal domain
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRGN
|
serglycin
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STATH
|
statherin
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK4
|
serine/threonine kinase 4
|
|
STRADB
|
STE20-related kinase adaptor beta
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN3
|
synapsin III
|
|
SYT11
|
synaptotagmin XI
|
|
SYVN1
|
synovial apoptosis inhibitor 1, synoviolin
|
|
TAC1
|
tachykinin, precursor 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TARP
|
TCR gamma alternate reading frame protein
|
|
TBC1D7
|
TBC1 domain family, member 7
|
|
TBX21
|
T-box 21
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TCEB1
|
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)
|
|
TCEB2
|
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B)
|
|
TDRD7
|
tudor domain containing 7
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFCP2
|
transcription factor CP2
|
|
TFF2
|
trefoil factor 2
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TG
|
thyroglobulin
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBRAP1
|
transforming growth factor, beta receptor associated protein 1
|
|
TGM2
|
transglutaminase 2
|
|
TGM6
|
transglutaminase 6
|
|
TH
|
tyrosine hydroxylase
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THOP1
|
thimet oligopeptidase 1
|
|
THPO
|
thrombopoietin
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIGAR
|
TP53 induced glycolysis regulatory phosphatase
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TIMM17B
|
translocase of inner mitochondrial membrane 17 homolog B (yeast)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TKT
|
transketolase
|
|
TKTL1
|
transketolase-like 1
|
|
TLK1
|
tousled-like kinase 1
|
|
TLN1
|
talin 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TM6SF2
|
transmembrane 6 superfamily member 2
|
|
TMEM106B
|
transmembrane protein 106B
|
|
TMEM109
|
transmembrane protein 109
|
|
TMEM161A
|
transmembrane protein 161A
|
|
TMEM173
|
transmembrane protein 173
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP3B
|
topoisomerase (DNA) III beta
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TOR2A
|
torsin family 2, member A
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPO
|
thyroid peroxidase
|
|
TPPP
|
tubulin polymerization promoting protein
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF5
|
TNF receptor-associated factor 5
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRAPPC9
|
trafficking protein particle complex 9
|
|
TRAV4
|
T cell receptor alpha variable 4
|
|
TRD
|
T cell receptor delta locus
|
|
TRDMT1
|
tRNA aspartic acid methyltransferase 1
|
|
TRDV2
|
T cell receptor delta variable 2
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREML1
|
triggering receptor expressed on myeloid cells-like 1
|
|
TREML2
|
triggering receptor expressed on myeloid cells-like 2
|
|
TRG
|
T cell receptor gamma locus
|
|
TRGV9
|
T cell receptor gamma variable 9
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM25
|
tripartite motif containing 25
|
|
TRIM32
|
tripartite motif containing 32
|
|
TRIM5
|
tripartite motif containing 5
|
|
TROVE2
|
TROVE domain family, member 2
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPAN1
|
tetraspanin 1
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTR
|
transthyretin
|
|
TTTY4
|
testis-specific transcript, Y-linked 4 (non-protein coding)
|
|
TUBA1A
|
tubulin, alpha 1a
|
|
TUBB
|
tubulin, beta class I
|
|
TUBB1
|
tubulin, beta 1 class VI
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXLNA
|
taxilin alpha
|
|
TXN
|
thioredoxin
|
|
TXN2
|
thioredoxin 2
|
|
TXNDC12
|
thioredoxin domain containing 12 (endoplasmic reticulum)
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UBB
|
ubiquitin B
|
|
UBD
|
ubiquitin D
|
|
UBE3C
|
ubiquitin protein ligase E3C
|
|
UBXN11
|
UBX domain protein 11
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UGT2B28
|
UDP glucuronosyltransferase 2 family, polypeptide B28
|
|
ULBP1
|
UL16 binding protein 1
|
|
ULBP3
|
UL16 binding protein 3
|
|
UMOD
|
uromodulin
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
USP13
|
ubiquitin specific peptidase 13 (isopeptidase T-3)
|
|
USP19
|
ubiquitin specific peptidase 19
|
|
USP21
|
ubiquitin specific peptidase 21
|
|
USP46
|
ubiquitin specific peptidase 46
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIMP
|
VCP-interacting membrane selenoprotein
|
|
VIP
|
vasoactive intestinal peptide
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VPS41
|
vacuolar protein sorting 41 homolog (S. cerevisiae)
|
|
VSNL1
|
visinin-like 1
|
|
VWA2
|
von Willebrand factor A domain containing 2
|
|
VWF
|
von Willebrand factor
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAGE1B
|
X antigen family, member 1B
|
|
XAGE1E
|
X antigen family, member 1E
|
|
XBP1
|
X-box binding protein 1
|
|
XCL1
|
chemokine (C motif) ligand 1
|
|
XCR1
|
chemokine (C motif) receptor 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
XRN2
|
5'-3' exoribonuclease 2
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZBTB7B
|
zinc finger and BTB domain containing 7B
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZC3HAV1
|
zinc finger CCCH-type, antiviral 1
|
|
ZCRB1
|
zinc finger CCHC-type and RNA binding motif 1
|
|
ZFAND2B
|
zinc finger, AN1-type domain 2B
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZNF689
|
zinc finger protein 689
|
